Share on Pinterest A new drug candidate called SAK3 successfully stopped the progression of a form of dementia in mice. Jacek Kadaj/Getty Images A drug candidate called SAK3 prevented further loss of ...

Proteins form the building blocks of life, but when they form unusual clumps inside the brain, they raise an alarm that ...

Please provide your email address to receive an email when new articles are posted on . In this video, James E. Galvin, MD, MPH, discusses the SHIMMER study, presented at the Alzheimer’s Association ...

(RTTNews) - CervoMed Inc. (CRVO) has announced positive 32-week data from the Extension phase of its phase IIb RewinD-LB trial of oral investigational drug Neflamapimod for the treatment of dementia ...

Detailed price information for Cognition Therapeutics Inc (CGTX-Q) from The Globe and Mail including charting and trades.

Neflamapimod, an experimental, oral drug targeting neuroinflammation being developed by CervoMed, led to a significant reduction in a key blood biomarker of neurodegeneration, which correlated with a ...

New research suggests that two proteins, amyloid- and phosphorylated tau, the key proteins of Alzheimer's disease, are detected in blood once symptoms have started in Lewy's body diseases, such as ...

Researchers from Denmark have uncovered strong evidence that depression often appears years before Parkinson’s disease and ...

Lewy body dementia (LBD) is a type of progressive disease that has affected more than a million Americans, according to the Lewy Body Dementia Association. Over time, it destroys brain cells and can ...

Lewy body dementia is a progressive neurodegenerative disorder brought on by an excess of the protein alpha-synuclein in the brain. These deposits, known as Lewy bodies, can inhibit the production of ...

Results from a new study reinforce the notion that dementia with Lewy bodies can be pathologically classified into two different disease types. Results obtained in a study recently completed at the ...